132-17-2CN1C2CCC1CC(OC(c1ccccc1)c1ccccc1)C2.CS(=O)(=O)OCPFJLLXFNPCTDW-UHFFFAOYSA-NSee also: Benztropine Mesylate (annotation moved to).
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
DescriptionBenztropine mesylate (132-17-2) is a centrally acting M1muscarinic acetylcholine receptor antagonist (Ki=0.59 nM, rat).1Also inhibits the dopamine transporter (Ki=160 nM).2Benztropine mesylate enhances remyelination and significantly decreases clinical severity in the experimental autoimmune encephalomyelitis model of relapsing-remitting multiple sclerosis alone or in combination with immunosuppressive agents.3Inhibits hepatitis C virus infection.4
UsesUsed as an antiparkinsonian.
UsesBenztropine mesylate is an anti-histamine and dopamine re-uptake inhibitor. It has been used to study its target identification and mode of action against ebolavirus infection. It has also been used in pharmacological animal studies to evaluate its effect on SLC6A19 (solute carrier family 6 member 19; B0AT1).
UsesBenzotropine methanesulfonate is used to treat the symptoms of Parkinsons disease and is currently in clincial trials for chronic back pain. It shows anti-muscarinic effects comparable to Atropine, and also demonstrates competitive anti-nicotinic action at the nAChR (nicotinic acetylcholine receptor).
General DescriptionBenztropine mesylate,3α-(diphenylmethoxy)-1αH,5αH-tropane methanesulfonate(Cogentin), has anticholinergic, antihistaminic, and localanesthetic properties. Its anticholinergic effect makes it applicableas an antiparkinsonian agent. It is about as potent ananticholinergic as atropine and shares some of the side effectsof this drug, such as mydriasis and dryness of mouth.Importantly, however, it does not produce central stimulationbut instead exerts the characteristic sedative effect ofthe antihistamines.
132-17-2CHEMBL85236DefinitionChEBI: The methanesulfonate salt of benzatropine. An acetylcholine receptor antagonist, it is used in the treatment of Parkinson's disease, and to reduce parkinsonism and akathisia side effects of antipsychotic treatments.